FULC
Fulcrum Therapeutics Inc
NASDAQ: FULC · HEALTHCARE · BIOTECHNOLOGY
$7.15
-3.90% today
Updated 2026-04-29
Market cap
$522.15M
P/E ratio
—
P/S ratio
2.66x
EPS (TTM)
$-1.18
Dividend yield
—
52W range
$4 – $16
Volume
1.2M
Fulcrum Therapeutics Inc (FULC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-25.30%
ROA
-16.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $0.00 | $-22.96M | — | — | — |
| 2018 | $0.00 | $-32.59M | — | — | — |
| 2019 | $750000.00 | $-79.11M | -273.73% | -11,228.93% | -10,548.40% |
| 2020 | $8.82M | $-68.44M | 100.00% | -811.64% | -775.70% |
| 2021 | $19.16M | $-78.33M | 100.00% | -422.97% | -408.77% |
| 2022 | $6.34M | $-109.87M | -1,110.69% | -1,774.85% | -1,732.43% |
| 2023 | $2.81M | $-97.33M | 100.00% | -3,945.24% | -3,470.05% |
| 2024 | $80.00M | $-9.72M | 20.77% | -27.37% | -12.16% |
| 2025 | $0.00 | $-74.88M | — | — | — |